Alzinova AB (publ) (ticker: ALZ) is pleased to announce the release of the drug substance for its upcoming Phase 2 clinical trial of the vaccine candidate ALZ-101 in early Alzheimer's disease. This mi ...

Researchers at the University of California San Diego and Wake Forest University have found that both low and moderate-high ...

Despite a lot of advancements in our understanding of dementia over the past few decades, doctors still don’t have a reliable ...

Pack  The Chronicle    People who are 65 years old today can expect to live an additional 19.3 years, on average, according ...

Caring for a parent with early-stage dementia can be overwhelming — but you don’t have to figure it out alone. The first step ...

Both GLP-1 RAs and SGLT2is are associated with a reduced risk for Alzheimer disease and related dementias among people with type 2 diabetes.

Brain tissue analysis of an animal model has revealed the potential role of immune system dysfunction in the onset and ...

Researchers have developed a tau-targeting vaccine that could help prevent the progression of Alzheimer’s disease by generating a strong immune response against abnormal tau proteins.

Zahydie Burgos Ribot and her husband Francisco are working on completing their travel bucket list and spending quality time ...

Blood vessels located at the back of the eye could potentially signal early signs of dementia, a recent study suggests.

With a new raise provided by Flagship Pioneering, the new company is aiming to find “the silent window” before disease symptoms set in.

In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop.